The only available automated test to determine the procoagulant activity of phospholipids
[mehr]
This innovating test is an indirect marker of Tissue Factor exposure In Vivo.
[mehr]
Rivaroxaban is a new oral anticoagulant developed by Bayer HealthCare and sold under the trade name Xarelto®. It is a direct factor Xa inhibitor approved for the prevention of VTE after hip or knee replacement surgery in more...
[mehr]
How can haemophilia A and type 2N von Willebrand disease be distinguished? To answer this question, Stago has developed a new diagnostic tool for VWF disease 2N: the Asserachrom® VWF:FVIIIB kit.
[mehr]12